Transcranial Direct Current Stimulation (tDCS) in the Treatment of Drug-naïve Obsessive-compulsive Disorder(OCD)
A Randomized Clinical Trial of Transcranial Direct Current Stimulation(tDCS) Treatment for Drug-naïve Obsessive-Compulsive Disorder(OCD)
1 other identifier
interventional
47
1 country
1
Brief Summary
This study will evaluate the possible therapeutic effects of Transcranial Direct Current Stimulation (tDCS) in drug-naïve obsessive-compulsive disorder (OCD) patients, and the underlying neural mechanism by magnetic resonance imaging (MRI),transcranial magnetic stimulation and electroencephalography (TMS-EEG).
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Nov 2019
Longer than P75 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
September 8, 2019
CompletedFirst Posted
Study publicly available on registry
September 11, 2019
CompletedStudy Start
First participant enrolled
November 5, 2019
CompletedPrimary Completion
Last participant's last visit for primary outcome
August 30, 2024
CompletedStudy Completion
Last participant's last visit for all outcomes
December 30, 2024
CompletedMay 15, 2025
May 1, 2025
4.8 years
September 8, 2019
May 12, 2025
Conditions
Outcome Measures
Primary Outcomes (1)
Change in Yale-Brown Obsessive Compulsive Scale(Y-BOCS) score
It assesses the severity of OCD symptoms. The Y-BOCS scale ranges from 0 to 40, with 0 being no symptoms and 40 being severe.The responder on Y-BOCS is defined as a Y-BOCS decrease at least 35% from the baseline at post-treatment.
Up to 3 months
Secondary Outcomes (6)
Change in Obsessive Compulsive Inventory-Revised(OCI-R)
Up to 3 months
Change in Beck Depression Inventory(BDI)
Up to 3 months
Change in Beck Anxiety Inventory (BAI)
Up to 3 months
Change in Perceived Stress Scale(PSS)
Up to 3 months
Change in Pittsburgh sleep quality index(PSQI)
Up to 3 months
- +1 more secondary outcomes
Study Arms (2)
active tDCS
ACTIVE COMPARATORCathode transcranial direct current stimulation over the right OFC will be applied once a day, 5 days a week, for 2 weeks.
sham tDCS
SHAM COMPARATORThe sham transcranial direct current stimulation over the right OFC will be applied once a day, 5 days a week, for 2 weeks.
Interventions
The tDCS device will deliver a direct current of 1.5mA during 20 minutes. Cathode electrode will be localized in front of the right OFC on the Fp2 point according to the EEG international reference. Four anode electrodes will be placed around FP2 (i.e. Fpz, AFz, AF4, AF8)
The same procedure will be applied except that the tDCS device will only deliver a current stimulation for the first and last 15 seconds.
Eligibility Criteria
You may qualify if:
- age: 18-50 years old;
- DSM-5 criteria for OCD;
- Y-BOCS total score \> or = 16, discontinued medication for at least 8 weeks before tDCS stimulation.
- \>or=9 years education
You may not qualify if:
- Any axis I psychiatric disorder comorbidity
- The inability to receive tDCS because of metallic implants, or history of seizures,or 3.history of head injury, or history of neurosurgery.
- Participants with claustrophobic, heart pacemaker, mechanical heart valve, mechanical implant such as an aneurysm clip, hip replacement, or any other pieces of metal that have accidentally entered their body.
- Any current significant medical condition.
- serious suicide risk
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Shanghai Mental Health Center
Shanghai, Shanghai Municipality, 200030, China
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Zhen Wang, PhD,MD
Shanghai Mental Health Center
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- TRIPLE
- Who Masked
- PARTICIPANT, INVESTIGATOR, OUTCOMES ASSESSOR
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- vice-president
Study Record Dates
First Submitted
September 8, 2019
First Posted
September 11, 2019
Study Start
November 5, 2019
Primary Completion
August 30, 2024
Study Completion
December 30, 2024
Last Updated
May 15, 2025
Record last verified: 2025-05
Data Sharing
- IPD Sharing
- Will not share